F. J. Acosta, J. L. Hernández, J. Pereira, J. Herrera, and C. J. Rodríguez, Medication adherence in schizophrenia, World J. Psychiatry, vol.2, issue.5, pp.74-82, 2012.

J. E. Aikens, D. E. Nease, D. P. Nau, M. S. Klinkman, and T. L. Schwenk, Adherence to maintenance-phase antidepressant medication as a function of patient beliefs about medication, Ann. Fam. Med, vol.3, issue.1, pp.23-30, 2005.

X. F. Amador, D. H. Strauss, S. A. Yale, M. M. Flaum, J. Endicott et al., Assessment of insight in psychosis, Am. J. Psychiatry, vol.150, issue.6, pp.873-879, 1993.

E. M. Beck, M. Cavelti, S. Kvrgic, B. Kleim, and R. Vauth, Are we addressing the 'right stuff' to enhance adherence in schizophrenia? Understanding the role of insight and attitudes towards medication, Schizophr. Res, vol.132, issue.1, pp.42-49, 2011.

E. M. Beck, R. Vögelin, M. Wirtz, M. Cavelti, S. Kvrgic et al., Do patients with schizophrenia distinguish between attitudes toward antipsychotic medication and pharmacotherapy in general? Validation of the Beliefs about Medication Questionnaire, J. Nerv. Ment. Dis, vol.200, issue.1, pp.33-43, 2012.

A. Bondesson, L. Hellström, T. Eriksson, and P. Höglund, A structured questionnaire to assess patient compliance and beliefs about medicines taking into account the ordered categorical structure of data, J. Eval. Clin. Pract, vol.15, issue.4, pp.713-723, 2009.

J. Clatworthy, R. Bowskill, R. Parham, T. Rank, J. Scott et al., Understanding medication non-adherence in bipolar disorders using a Necessity-Concerns Framework, J. Affect. Disord, vol.116, issue.1-2, pp.51-55, 2009.

J. C. Day, G. Wood, M. Dewey, and R. P. Bentall, A self-rating scale for measuring neuroleptic side-effects. Validation in a group of schizophrenic patients, Br. J. Psychiatry, vol.166, issue.5, pp.650-653, 1995.

R. C. Hall, Global assessment of functioning. A modified scale, Psychosomatics, vol.36, issue.3, pp.267-275, 1995.

R. Horne and J. Weinman, Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness, J. Psychosom. Res, vol.47, issue.6, pp.555-567, 1999.

R. Horne, J. A. Weinman, and M. Hankins, The Beliefs about Medicines Questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication, Psychol. Health, vol.14, pp.1-25, 1999.

R. Horne, S. C. Chapman, R. Parham, N. Freemantle, A. Forbes et al., Understanding patients' adherence-related beliefs about medicines prescribed for longterm conditions: a meta-analytic review of the Necessity-Concerns Framework, PLoS One, vol.8, issue.12, p.80633, 2013.

H. Jónsdóttir, S. Friis, R. Horne, K. I. Pettersen, A. Reikvam et al., Beliefs about medications: measurement and relationship to adherence in patients with severe mental disorders, Acta Psychiatr. Scand, vol.119, issue.1, pp.78-84, 2009.

S. R. Kay, A. Fiszbein, and L. A. Opler, The positive and negative syndrome scale (PANSS) for schizophrenia, Schizophr. Bull, vol.13, issue.2, pp.261-276, 1987.

P. M. Llorca, Partial compliance in schizophrenia and the impact on patient outcomes, Psychiatry Res, vol.161, issue.2, pp.235-247, 2008.

D. E. Morisky, L. W. Green, and D. M. Levine, Concurrent and predictive validity of a selfreported measure of medication adherence, Med. Care, vol.24, issue.1, pp.67-74, 1986.

D. Novick, J. M. Haro, D. Suarze, V. Perez, R. W. Dittmann et al., Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia, Psychiatry Res, vol.176, pp.109-113, 2010.

T. L. Patterson and O. R. Leeuwenkamp, Adjunctive psychosocial therapies for the treatment of schizophrenia, Schizophr. Res, vol.100, issue.1-3, pp.108-119, 2008.

K. J. Preacher and A. F. Hayes, SPSS and SAS procedures for estimating indirect effects in simple mediation models, Behav. Res. Methods Instrum. Comput, vol.36, issue.4, pp.717-731, 2004.

N. Rüsch, A. R. Todd, G. V. Bodenhausen, P. J. Weiden, and P. W. Corrigan, Implicit versus explicit attitudes toward psychiatric medication: implications for insight and treatment adherence, Schizophr. Res, vol.112, issue.1-3, pp.119-122, 2009.

D. Velligan, P. J. Weiden, M. Sajatovic, J. Scott, D. Carpenter et al., The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness, J. Clin. Psychiatry, vol.70, pp.1-46, 2009.

N. Yalcin-siedentopf, F. Wartelsteiner, A. Kaufmann, F. Biedermann, M. Edlinger et al., Measuring adherence to medication in schizophrenia: the relationship between attitudes toward drug therapy and plasma levels of new-generation antipsychotics, Int. J. Neuropsychopharmacol, vol.8, issue.5, pp.1-7, 2015.